Washington, DC (PRWEB) June 20, 2008
Cardiocore, a leading cardiac core laboratory, announced today that it has hired European core lab veteran Nicholas Campbell BSc, MBA. Mr. Campbell joins Cardiocore as Vice President, Business Development Europe & Asia, and will be located at the company's European offices in London.
Mr. Campbell has extensive operations management and business development expertise from previous leadership roles at Europe-based cardiac core labs. Most recently, he was Director, European Cardiac Safety Services and Director, Business Development for Covance Cardiac Safety Services. Prior to Covance, Mr. Campbell was ECG Core Laboratory Manager and Director, Business Development for Cardio Analytics.
"I am delighted to welcome Nick," said Cardiocore's Chief Executive Officer, Jennifer Cotteleer, adding, "He's a seasoned and respected professional, driven to deliver the customer care that Cardiocore's worldwide clients rely upon. Nick's leadership will help ensure that Cardiocore's sponsor-focused delivery model continues to surpass traditional core lab performance standards in every region around the globe."
"In deciding to join Cardiocore," Mr. Campbell noted, "I was heavily influenced by feedback from pharmaceutical and biotech executives. Sponsors in Europe, Asia and North America appreciate Cardiocore as a team of expert consultants who listen carefully to their needs and commit themselves to delivering real solutions."
Cardiocore has provisioned sites in nearly every country where clinical trials are undertaken and has mastered the logistical support necessary for those sites to succeed. The company's proprietary web service, the CardioPortal™, offers unprecedented information access and controls to sites and sponsors around the globe.
Cardiocore has provided superior centralized cardiac testing services to the pharmaceutical and biotech industries for 15 years. Services include centralized electrocardiographic (ECG) analysis, Holter monitoring, echocardiography, statistical analysis and consulting services such as protocol design. The company is experienced in design and implementation of Thorough QT Trials and cardiac safety and efficacy testing in Phase I, II and III clinical trials. These services are supported by the company's CardioCorrect® system featuring the proprietary HolterGateway™ and CardioPortal™. Cardiocore's U.S. headquarters is located in Bethesda, Maryland, its West Coast office is located in San Francisco, California, and its European subsidiary, Cardiocore Limited, is located in London, England.
# # #